Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

Cited by (289)

Items 101–200 of 289

1. Two Cases of Thyroid Carcinoma That Were Not Stimulated by Recombinant Human Thyrotropin
   A. A. Driedger, Natalie Kotowycz · 2004 · The Journal of Clinical Endocrinology & Metabolism
2. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels
   Gabriella Pellegriti, Claudia Scollo, Concetto Regalbuto, Marco Attard, Paola Marozzi, Francesco Vermiglio, Maria A. Violi, Michelangela Cianci, Riccardo Vigneri, VINCENZO PEZZINO et al. · 2003 · Clinical Endocrinology
3. Health-Related Quality of Life following Total Thyroidectomy and Lobectomy for Differentiated Thyroid Carcinoma: A Systematic Review
   Vivianne Landry, E A Siciliani, Mélissa Henry, Richard J. Payne · 2022 · Current Oncology
4. Influence of Body Surface Area on Serum Peak Thyrotropin (TSH) Levels after Recombinant Human TSH Administration
   Giovanni Vitale, Giovanni Lupoli, Antonio Ciccarelli, A Lucariello, Maria Rosa Fittipaldi, Francesco Fonderico, Annalisa Panico, Giovanni Lupoli · 2003 · The Journal of Clinical Endocrinology & Metabolism
5. Quality of life aspects in the management of thyroid cancer
   Heying Duan, Eva‐Maria Gamper, Alexander Becherer, M. Hoffmann · 2015 · Oral Oncology
6. Persistent Posttreatment Fatigue in Thyroid Cancer Survivors
   Anna M. Sawka, Asima Naeem, Jennifer Michelle Jones, Julia M. LOWE, Philip Segal, Jeannette Goguen, Jeremy D. Gilbert, Afshan Zahedi, Catherine Margaret Kelly, Shereen Ezzat · 2014 · Endocrinology and Metabolism Clinics of North America
7. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer
   S. Altuntaş, Ç. Hocaoğlu · 2021 · Hormone and Metabolic Research
8. Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma
   Massimo Giusti, Giulia Melle, Monica Fenocchio, Lorenzo Mortara, Francesca Cecoli, Valeria Caorsi, Diego Ferone, Francesco M. Minuto, Elda Rasore · 2011 · Journal of Zhejiang University SCIENCE B
9. Diminished Quality of Life and Increased Brain Functional Connectivity in Patients with Hypothyroidism After Total Thyroidectomy
   Yong‐Wook Shin, Yun Mi Choi, Ho Sung Kim, Dae‐Jin Kim, Hang Joon Jo, Brian F. O’Donnell, Eun Kyung Jang, Tae Yong Kim, Young Kee Shong, Jin Pyo Hong et al. · 2016 · Thyroid
10. Health‐Related Quality‐of‐Life Study in Patients With Carcinoma of the Thyroid After Thyroxine Withdrawal for Whole Body Scanning
    Sin‐Ming Chow, Kwok‐Hung Au, Tim‐Shing Choy, Siu‐Hong Lee, Nga‐Yan Yeung, Angus Kwong‐Chuen Leung, Alex Leung, Hoi‐Leung Leung, Chi Chung Shek, Stephen C.K. Law · 2006 · The Laryngoscope
11. Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH
    Nikos Emmanouilidis, Jörg Andreas Müller, Mark D. Jäger, Stephan Kaaden, Fabian Helfritz, Zeynep Esra Güner, Holger Kespohl, Wolfgang Knitsch, Wolfram H. Knapp, Jurgen L. Klempnauer et al. · 2009 · European Journal of Endocrinology
12. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer
    Martin Jean Schlumberger, Marcel Ricard, Gérard de Pouvourville, Furio Pacini · 2007 · Nature Clinical Practice Endocrinology & Metabolism
13. Development and Evaluation of a Korean Version of a Thyroid-Specific Quality-of-Life Questionnaire Scale in Thyroid Cancer Patients
    Chang Hwan Ryu, Boram Park, Junsun Ryu, Youn Mi Ryu, Seong Ae Jo, You Jin Lee, Eun Kyung Lee, Yul Hwangbo, Jungnam Joo, Yuh‐Seog Jung · 2017 · Cancer Research and Treatment
14. Present status of the use of recombinant human TSH in thyroid cancer management
    Markus Luster · 2006 · Acta Oncologica
15. A review of the potential uses for recombinant human TSH in patients with thyroid cancer and nodular goiter
    Whitney W. Woodmansee, Bryan R. Haugen · 2004 · Clinical Endocrinology
16. Recombinant Human Thyrotropin is Helpful in the Follow-Up and 131 I Therapy of Patients with Thyroid Cancer: A Report of the Results and Benefits Using Recombinant Human Thyrotropin in Clinical Routine
    Susanne Kohlfürst, I. Igerc, Peter Lind · 2005 · Thyroid
17. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
    Jolanta M. Durski, Ronald J. Weigel, Iain Ross McDougall · 2000 · Nuclear Medicine Communications
18. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
    Chao Ma, Jiawei Xie, Wanxia Liu, Guo‐Ming Wang, Shuyao Zuo, Xufu Wang, Fengyu Wu · 2010 · Cochrane Database of Systematic Reviews
19. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer
    Chang Liu, Yu Pan, Qinyu Li, Yifan Zhang · 2021 · International Journal of Medical Sciences
20. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal
    Angela Vaiano, Claudio Traino, Giuseppe Boni, Mariano Grosso, Patrizia Lazzeri, Chiara Colato, Maria Vittoria Davì, Giorgio Francia, Mauro Lazzeri, Giuliano Mariani et al. · 2007 · Nuclear Medicine Communications
21. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid carcinoma
    Iain Ross McDougall · 1999 · Nuclear Medicine Communications
22. A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer
    Birte Nygaard, Lars Bastholt, Finn Noe Bennedbæk, Tobias Wirenfeldt Klausen, Jens Bentzen · 2013 · European Thyroid Journal
23. Three‐Week Thyroxine Withdrawal: A Thyroid‐Specific Quality of Life Study
    Taryn Davids, Ian Witterick, Spiro J. Eski, Paul G. Walfish, Jeremy L. Freeman · 2006 · The Laryngoscope
24. In Thyroidectomized Patients with Thyroid Cancer, a Serum Thyrotropin of 30 μ U/mL After Thyroxine Withdrawal Is Not Always Adequate for Detecting an Elevated Stimulated Serum Thyroglobulin
    Laticia A. Valle, Revital L. Gorodeski Baskin, Kyle M. Porter, Jennifer A. Sipos, Raheela A. Khawaja, Matthew David Ringel, Richard T. Kloos · 2012 · Thyroid
25. Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer
    Concetto Regalbuto, Corradina Alagona, Raffaella Maiorana, R. Di Paola, Michelangela Cianci, Giovanna Alagona, S. Sapienza, Riccardo Vigneri, VINCENZO PEZZINO · 2006 · Journal of Endocrinological Investigation
26. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
    Elizabeth J. de Koster, Dennis Vriens, Maarten O. van Aken, Lioe-Ting Dijkhorst-Oei, Wim J.G. Oyen, Robin Patrick Peeters, Abbey Schepers, Lioe‐Fee de Geus‐Oei, Wilbert B. van den Hout, for the EfFECTS trial study group · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
27. Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study
    THYROPET study group, Jakob W. Kist, Bart de Keizer, Marcel P. M. Stokkel, Otto S. Hoekstra, Wouter V. Vogel · 2014 · BMC Cancer
28. The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal.
    Mateja Rubic, Sanja Kusačić Kuna, Vanja Tešić, Tatjana Samardžić, Marija Despot, Dražen Huić · 2014 · PubMed
29. Perceived and actual change in religion/spirituality in cancer survivors: Longitudinal relationships with distress and perceived growth.
    Kelly M. Trevino, Aanand Dinkar Naik, Jennifer A. Moye · 2015 · Psychology of Religion and Spirituality
30. Childhood Thyroid Cancers and Radioactive Iodine Therapy: Necessity of Precautious Radiation Health Risk Management
    Atsushi Kumagai, Christoph Reiners, Валентина Дрозд, Shunichi Yamashita · 2007 · Endocrine Journal
31. Quality of Life, Anxiety and Depression in Patients with Differentiated Thyroid Cancer under Short Term Hypothyroidism Induced by Levothyroxine Withdrawal
    Shervin Badihian, Pouyan Jalalpour, Mirdamadi Motahareh, Masoud Moslehi · 2016 · Klinicka onkologie
32. Practical Management of Thyroid Cancer
    2018 · Springer eBooks
33. International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34
    Susanne Singer, Akram Al‐Ibraheem, Monica Pinto, Ioannis P. Iakovou, Arild Andrè Østhus, Eva B. Hammerlid, Laura D. Locati, Eva‐Maria Gamper, Juan Ignácio, Susan J. Jordan et al. · 2023 · Thyroid
34. Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol
    Deepa Rani, Sushma Kaisar, Sushma Awasare, Kamaldeep, Amit Abhyankar, Sandip Kanti Basu · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
35. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
    Krishnamachar Harish · 2006 · PubMed
36. Psychological status and quality of life associated with radioactive iodine treatment of patients with differentiated thyroid cancer: Results of hospital anxiety and depression scale and short-form (36) health survey
    Mohsen Qutbi, Seyedshahab Banihashem, Mehdi Arabzadeh, ReyhanehSadat Jafarian Bahri · 2020 · Indian Journal of Nuclear Medicine
37. Standard and Emerging Therapeutic Approaches for Thyroid Malignancies
    Rebecca L. Brown · 2008 · Seminars in Oncology
38. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine
    Maria Laura Monzani, F. Piccinini, Gisella Boselli, Rossella Corleto, Gianluca Margiotta, Robin Patrick Peeters, Manuela Simoni, Giulia Brigante · 2022 · Journal of Endocrinological Investigation
39. Assessing Hypothyroidism in the Preparation of Patients With Thyroid Cancer
    Pedro Weslley Souza Ros rio, Tales Alvarenga Fagundes, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Michelle Aparecida Ribeiro Borges, Álvaro Luís Barroso · 2006 · The Endocrinologist
40. Non-surgical Management of Thyroid Cancer
    Masud S. Haq, Clive Harmer · 2006 · Springer eBooks
41. A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma Favoring Active Surveillance Over Surgery
    Ji Ye Lee, Dong Gyu Na, Jung Suk Sim, Jin Yong Sung, Sun Wook Cho, Do Joon Park, Young Joo Park, Ji‐hoon Kim · 2024 · Thyroid
42. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans
    Grigorios Panagiotou, Kalliopi Pazaitou‐Panayiotou, Stavroula Α. Paschou, Despina Komninou, Nikolaos Kalogeris, Andromachi Vryonidou, Christos Socrates Mantzoros · 2016 · Thyroid
43. Recombinant Human Thyrotropin in Thyroid Cancer and Hypopituitarism Due to Sella Metastasis
    Jörn H. Risse, Frank Grünwald, H. Bender, H. Schüller, Dirk Van Roost, HANS-JÜRGEN BIERSACK · 1999 · Thyroid
44. Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: Why, how and when
    Daniele Barbaro, Giuseppe Boni · 2007 · European Journal of Surgical Oncology
45. Assessment of anxiety levels of patients awaiting surgery for suspected thyroid cancer: A case‐control study in a Chinese‐Han population
    Yu Yang, Hui Ma, Man Wang, Aiping Wang · 2016 · Asia-Pacific Psychiatry
46. Recombinant human TSH in radioiodine treatment of differentiated thyroid cancer.
    Roussanka Dimitrova Kovatcheva, Tatjana D Hadjieva, Georgi Кirilov, B Lozanov · 2004 · PubMed
47. Molecular nuclear therapies for thyroid carcinoma
    Frederik A. Verburg, Boudewijn T. Brans, Felix Manuel Mottaghy · 2011 · Methods
48. Recombinant human TSH versus hypo thyroidism
    S. Busemeyer, Carsten Kobe, M. Schmidt, PETER THEISSEN, H Schicha, Markus Dietlein · 2010 · Nuklearmedizin - NuclearMedicine
49. Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy
    Hee Jeong Park, Jung‐Joon Min, Hee‐Seung Bom, Jahae Kim, Ho‐Chun Song, Seong Young Kwon · 2017 · Annals of Nuclear Medicine
50. Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer
    Daria Handkiewicz-Junak, Tomasz Gawlik, Jozef Rozkosz, Zbigniew Puch, Barbara Michalik, Elżbieta Gubała, Jolanta Krajewska, Aneta Kluczewska-Gałka, Barbara Jarząb · 2015 · European Journal of Endocrinology
51. Draft of the clinical recommendations for diagnosis and treatment of hypothyroidism
    Valentin V. Fadeev, Т. Б. Моргунова, Galina Afanas'evna Mel'nichenko, Ivan Ivanovich Dedov · 2021 · Clinical and experimental thyroidology
52. Recombinant human thyrotropin in the management of thyroid disorders
    Gilberto Paz-Filho, Hans Graf · 2008 · Expert Opinion on Biological Therapy
53. Unemployment Risk and Decreased Income Two and Four Years After Thyroid Cancer Diagnosis: A Population-Based Study
    Navah Zelda Ratzon, Beatrice Uziely, Angela G. E. M. de Boer, Yakir Rottenberg · 2016 · Thyroid
54. Recombinant Human Thyroid-Stimulating Hormone: Use in Papillary and Follicular Thyroid Cancer
    Martin Jean Schlumberger, Isabelle Borget, Gérard de Pouvourville, Furio Pacini · 2007 · Hormone Research in Paediatrics
55. Systemic radiation therapy with unsealed radionuclides
    Iain Ross McDougall · 2000 · Seminars in Radiation Oncology
56. Returning to work by thyroid cancer survivors 5 years after diagnosis: the VICAN survey
    Gwenaëlle Creff, F. Jégoux, Marc‐Karim Bendiane, E. Babin, Idlir Licaj · 2021 · Journal of Cancer Survivorship
57. Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort
    Min Joo Kim, Hojeong Won, Won Bae Kim, Eun Kyung Lee, Chang Yoon Lee, Sun Wook Cho, Han-Sang Baek, Yong Sang Lee, Yae Eun Kang, Sun Wook Kim et al. · 2024 · Thyroid
58. Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation
    Otmar Schober, B. Riemann, Alexis Vrachimis · 2012 · Nuklearmedizin - NuclearMedicine
59. Evaluation of whole-body retention of iodine-131 (131I) after postoperative remnant ablation for differentiated thyroid carcinoma – thyroxine withdrawal versus rhTSH administration: A retrospective comparison
    Maria Raquel Santos Carvalho, TERESA C. FERREIRA, Valeriano Alberto Pais Horta Leite · 2011 · Oncology Letters
60. Factors affecting the health-promoting behavior of thyroid cancer survivors: comparison by stage of cancer survivorship
    Kyung Ah Park, Sanghee Kim, Eui Geum Oh, Heejung Kim, Hang‐Seok Chang, Soo Hyun Kim · 2022 · Supportive Care in Cancer
61. Assessing health status and quality of life of cancer patients: the use of general instruments
    Pennifer Erickson · 2004 · Cambridge University Press eBooks
62. Recombinant human thyroid-stimulating hormone-aided scintigraphy: comparison of imaging at multiple times after I-131 administration.
    Salil D. Sarkar, M. O. Afriyie, Christopher J. Palestro · 2001 · Clinical Nuclear Medicine
63. Differentiated thyroid cancer: comparison of therapeutic iodine 131 biological elimination after discontinuation of levothyroxine versus administration of recombinant human thyrotropin
    Dimitris Papadimitriou, Sofia Kottou, Loukia Oros, Ιoannis Ilias, M. Molfetas, Virginia Tsapaki, A. Perris, Ioulia Christakopoulou · 2006 · Annals of Nuclear Medicine
64. The use of recombinant human thyrotropin (Thyrogen) in the diagnosis and treatment of thyroid cancer
    Leonidas H. Duntas, Nikolaos Tsakalakos, Brigitte Maria Grab-Duntas, Maria Kalarritou, Elli Lakka-Papadodima · 2003 · HORMONES
65. Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study
    Floortje Mols, Dounya Schoormans, Romana Teodora Netea-Maier, Olga Husson, Sandra Beijer, Katrijn Van Deun, Wouter T. Zandee, Marleen Kars, Pleun Wouters–van Poppel, Suat Şimşek et al. · 2023 · Thyroid Research
66. Long-Term Results after Treatment of Very Low-, Low-, and High-Risk Thyroid Cancers in a Combined Setting of Thyroidectomy and Radio Ablation Therapy in Euthyroidism
    Nikos Emmanouilidis, Harald Schrem, Michael Winkler, Jurgen L. Klempnauer, Georg F. W. Scheumann · 2013 · International Journal of Endocrinology
67. Thyroid Hormone Effects on Sensory Perception, Mental Speed, Neuronal Excitability and Ion Channel Regulation
    Irmgard D. Dietzel, Sivaraj Mohanasundaram, Vanessa Niederkinkhaus, Gerd Hoffmann, Jens Wiltfang, Christoph Reiners, Christiana Blasl, Katharina Bohr · 2012 · InTech eBooks
68. TSH recombinante no tratamento e seguimento de pacientes com carcinoma diferenciado de tireóide: uso na prática clínica
    Pedro Weslley Rosário, Tales Alvarenga Fagundes, Saulo Purisch, Eduardo Lanza Padrao, Leonardo Lamego Rezende, Álvaro Luís Barroso · 2005 · Arquivos Brasileiros de Endocrinologia & Metabologia
69. Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
    Seo Young Sohn, Hye Won Jang, Yoon Young Cho, Sun Wook Kim, Jae Hoon Chung · 2015 · Endocrinology and Metabolism
70. Cardiovascular Safety of Acute Recombinant Human Thyrotropin Administration to Patients Monitored for Differentiated Thyroid Cancer
    Bernadette Biondi, Emiliano A. Palmieri, Loredana Pagano, Michele Klain, Giovanna Scherillo, Marco Salvatore, Gianfranco Fenzi, Gaetano Lombardi, Sergio Fazio · 2003 · The Journal of Clinical Endocrinology & Metabolism
71. Clinical Factors Associated with Quality of Life in Patients with Thyroid Cancer
    Hyung‐Jun Yoon, Jeong‐Ho Seok · 2014 · Journal of Korean Thyroid Association
72. Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
    Ivana Žagar, Andreja A. Schwarzbartl-Pevec, Barbara Vidergar‐Kralj, Rika Horvat, Nikola Bešič · 2011 · Journal of Thyroid Research
73. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
    Fabián Pitoia, E. El Tamer, Daniel Schere, Mariano Passerieu, Oscar Domingo Bruno, Hugo Nièpomniszcze · 2006 · PubMed
74. Use of recombinant thyrotropin
    Anthony D. Toft, Geoffrey J. Beckett · 2002 · The Lancet
75. Modern Management of Differentiated Thyroid Cancer
    Jason B. Cohen, Judy E. Kalinyak, Iain Ross McDougall · 2003 · Cancer Biotherapy and Radiopharmaceuticals
76. Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery
    Christine J. O’Neill, Christopher W. Rowe, Harriet Morris‐Baguley, Melissa A. Carlson, Sarah Leask, Tara Clinton‐McHarg, Elizabeth G. Holliday, Elizabeth A. Fradgley, Christine Louise Paul · 2025 · Thyroid
77. Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)
    Ja Kyung Lee, Eu Jeong Ku, Su‐jin Kim, Woochul Kim, Jae Won Cho, Kyong Yeun Jung, Hyeong Won Yu, Yea Eun Kang, Mijin Kim, Hee Kyung Kim et al. · 2024 · Annals of Surgical Treatment and Research
78. Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma
    Alessia David, Annabella Blotta, Roberta Rossi, Maria Chiara Zatelli, Marta Bondanelli, Elio Roti, Lewis E. Braverman, Luciano Busutti, Ettore C. degli Uberti · 2005 · Thyroid
79. La TSH humana recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides
    P. Gómez Camarero, María Asunción Martínez Brocca, José Ramón Rodríguez, Elena Navarro González, D. González Duarte, R. Vázquez Albertino, Reyes Jiménez · 2003 · Revista Española de Medicina Nuclear
80. Optimum Recombinant Human Thyrotropin Dose in Patients With Differentiated Thyroid Carcinoma and End-Stage Renal Disease
    Fabián Pitoia, Verónica Ilera, María Belén Zanchetta, Adriana Foffano, Hugo Nièpomniszcze · 2008 · Endocrine Practice
81. Social and sexual health of thyroid cancer survivors 2 and 5 years after diagnosis: the VICAN survey
    Gwenaëlle Creff, F. Jégoux, Marc‐Karim Bendiane, E. Babin, Idlir Licaj · 2021 · Supportive Care in Cancer
82. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma
    Ji Young Joung, Ji Hun Choi, Yoon Young Cho, Na Kyung Kim, Seo Young Sohn, Sun Wook Kim, Jae Hoon Chung · 2014 · American Journal of Clinical Oncology
83. Cost-effectiveness of using recombinant human thyroid-stimulating hormone before radioiodine ablation for thyroid cancer treatment in Spanish hospitals
    Juan Antonio Vallejo, Maria Angustias Muros · 2017 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
84. Structural Equation Modeling on Health-related Quality of Life among Patients with Thyroid Cancer
    Seon-Young Lee, Hyun Kyung Kim · 2018 · Korean Journal of Adult Nursing
85. Fast-track Radioiodine Ablation Therapy After Thyroidectomy Reduces Sick Leave in Patients With Differentiated Thyroid Cancer (FASTHYNA Trial)
    Farahnaz Waissi, Jakob W. Kist, Lutske Lodewijk, G. Ardine de Wit, Jos A. van der Hage, Thijs van Dalen, Bart de Keizer, Gerlof Dirk Valk, Inne H.M. Borel Rinkes, Menno Reginaldus Vriens · 2018 · Clinical Nuclear Medicine
86. Clinical uses of recombinant human thyrotropin
    Loukas Gourgiotis, Monica C. Skarulis · 2004 · Expert Opinion on Pharmacotherapy
87. Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
    Yodphat Krausz, Beatrice Uziely, Rafael Nesher, Roland Chisin, Benjamin Gläser · 2001 · PubMed
88. Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study
    Shivakumar Thiagarajan, Khuzema Saifuddin Fatehi, Nandini N. Menon, Mahesh Sawant, Ankita Pal · 2024 · European Archives of Oto-Rhino-Laryngology
89. Comparison of conventional l-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing
    Ilenia Marturano, Marco Russo, A. Spadaro, Adele Latina, Pasqualino Malandrino, Concetto Regalbuto · 2015 · Journal of Endocrinological Investigation
90. Preparation with Recombinant Humanized Thyroid-Stimulating Hormone before Radioiodine Ablation after Thyroidectomy: A Systematic Review
    John J. Yoo, Roxanne Cosby, A A Driedger · 2009 · Current Oncology
91. Development and Validation of a Thyroid Cancer-Specific Health-Related Quality of Life Questionnaire for Adult Filipinos with Differentiated Thyroid Cancer
    Ralph Jason Li, Cecilia Jimeno, Mark Anthony Sandoval, Arsenio Claro A. Cabungcal, Ruben V. Ogbac, Gemma Leonora Uy · 2016 · Journal of the ASEAN Federation of Endocrine Societies
92. Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian population
    Charlene Yu Lin Tang, Sue Ping Thang, Sumbul Zaheer, Chung Kong Kwan, David Chee‐Eng Ng · 2020 · Endocrine
93. Treatment of Hypothyroidism
    Jacqueline Jonklaas · 2019 · Springer eBooks
94. Aplicación de la TSH humana recombinante en el protocolo diagnóstico del cáncer diferenciado de tiroides
    J.M. Jiménez-Hoyuela García, José Manuel García Almeida, Alberto Delgado García, Isabel Aguilar Fernández, M.D. Martínez del Valle Torres, S. Ortega Lozano, A. Rebollo Aguirre, Isabel Mancha Doblas, José Luis Martín, María José Picón César et al. · 2005 · Revista Española de Medicina Nuclear
95. Reproducibility of whole-body 131I scan and serum thyrotropin and stimulated thyroglobulin values in patients studied twice after injection of recombinant human thyrotropin
    Ryan D. Niederkohr, Iain Ross McDougall · 2006 · European Journal of Nuclear Medicine and Molecular Imaging
96. The needs of family members of patients receiving radioactive iodine
    Margaret I. Fitch, Petrina N. McGrath · 2003 · Canadian Oncology Nursing Journal
97. The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Milena Braga‐Basaria, Hans Graf, David S. Cooper · 2002 · The American Journal of Medicine
98. Impact of age and sex on the quality of life following radioactive iodine ablation in patients with thyroid cancer
    Seunghyeon Shin, Keun-young Kim A, Bum‐Soo Kim, Seong‐Jang Kim, Wonjae Cha, Jeon Yeob Jang, Byung‐Joo Lee, Yun Kyung Jeon, Sang Soo Kim, Bo Hyun Kim et al. · 2017 · Nuklearmedizin - NuclearMedicine
99. Quality of life comparison in thyroxine hormone withdrawal versus triiodothyronine supplementation prior to radioiodine ablation in differentiated thyroid carcinoma: a prospective cohort study in the Indian population
    Saravana Rajamanickam, Devendra Arvind Chaukar, Somiah Siddiq, Sandip Kanti Basu, Anil Keith Dcruz · 2021 · European Archives of Oto-Rhino-Laryngology
100. Quality of Life in Head & Neck Surgical Oncology and Thyroid Surgery
     George Garas, Keshav Kumar Gupta, Sameer Mallick · 2023 · Springer eBooks